These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Thyroid lobectomy for papillary thyroid cancer: long-term follow-up study of 1,088 cases. Matsuzu K, Sugino K, Masudo K, Nagahama M, Kitagawa W, Shibuya H, Ohkuwa K, Uruno T, Suzuki A, Magoshi S, Akaishi J, Masaki C, Kawano M, Suganuma N, Rino Y, Masuda M, Kameyama K, Takami H, Ito K. World J Surg; 2014 Jan; 38(1):68-79. PubMed ID: 24081532 [Abstract] [Full Text] [Related]
5. Clinicopathological features of recurrent papillary thyroid cancer. Zhu J, Wang X, Zhang X, Li P, Hou H. Diagn Pathol; 2015 Jul 14; 10():96. PubMed ID: 26168921 [Abstract] [Full Text] [Related]
6. Robot-assisted Sistrunk's operation, total thyroidectomy, and neck dissection via a transaxillary and retroauricular (TARA) approach in papillary carcinoma arising in thyroglossal duct cyst and thyroid gland. Byeon HK, Ban MJ, Lee JM, Ha JG, Kim ES, Koh YW, Choi EC. Ann Surg Oncol; 2012 Dec 14; 19(13):4259-61. PubMed ID: 23070784 [Abstract] [Full Text] [Related]
8. Routine central lymph node dissection with total thyroidectomy for papillary thyroid cancer potentially minimizes level VI recurrence. Hall CM, Snyder SK, Maldonado YM, Lairmore TC. Surgery; 2016 Oct 14; 160(4):1049-1058. PubMed ID: 27521047 [Abstract] [Full Text] [Related]
11. Excellent Prognosis of Central Lymph Node Recurrence-Free Survival for cN0M0 Papillary Thyroid Carcinoma Patients Who Underwent Routine Prophylactic Central Node Dissection. Ito Y, Miyauchi A, Masuoka H, Fukushima M, Kihara M, Miya A. World J Surg; 2018 Aug 14; 42(8):2462-2468. PubMed ID: 29372373 [Abstract] [Full Text] [Related]
12. Rationality in prophylactic central neck dissection in clinically node-negative (cN0) papillary thyroid carcinoma: Is there anything more to say? A decade experience in a single-center. Dobrinja C, Troian M, Cipolat Mis T, Rebez G, Bernardi S, Fabris B, Piscopello L, Makovac P, Di Gregorio F, de Manzini N. Int J Surg; 2017 May 14; 41 Suppl 1():S40-S47. PubMed ID: 28506412 [Abstract] [Full Text] [Related]
13. Role of BRAF V600E mutation as an indicator of the extent of thyroidectomy and lymph node dissection in conventional papillary thyroid carcinoma. Kim SK, Woo JW, Lee JH, Park I, Choe JH, Kim JH, Kim JS. Surgery; 2015 Dec 14; 158(6):1500-11. PubMed ID: 26120069 [Abstract] [Full Text] [Related]
14. Coexistence of chronic lymphocytic thyroiditis and papillary thyroid carcinoma. Impact on presentation, management, and outcome. Dobrinja C, Makovac P, Pastoricchio M, Cipolat Mis T, Bernardi S, Fabris B, Piscopello L, de Manzini N. Int J Surg; 2016 Apr 14; 28 Suppl 1():S70-4. PubMed ID: 26708864 [Abstract] [Full Text] [Related]
19. Risk factors and indication for dissection of right paraesophageal lymph node metastasis in papillary thyroid carcinoma. Zhang L, Liu H, Xie Y, Xia Y, Zhang B, Shan G, Li X. Eur J Surg Oncol; 2016 Jan 14; 42(1):81-6. PubMed ID: 26615455 [Abstract] [Full Text] [Related]
20. Multifocality, but not bilaterality, is a predictor of disease recurrence/persistence of papillary thyroid carcinoma. Kim HJ, Sohn SY, Jang HW, Kim SW, Chung JH. World J Surg; 2013 Feb 14; 37(2):376-84. PubMed ID: 23135422 [Abstract] [Full Text] [Related] Page: [Next] [New Search]